Marina Pasca di Magliano Selected Research

FLP recombinase

1/2020

Differential Contribution of Pancreatic Fibroblast Subsets to the Pancreatic Cancer Stroma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marina Pasca di Magliano Research Topics

Disease

24	Neoplasms (Cancer) 01/2022 - 12/2011
21	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 02/2012
8	Adenocarcinoma 11/2022 - 08/2013
6	Carcinogenesis 01/2021 - 04/2013
4	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2010
4	Pancreatitis 01/2021 - 03/2014
3	Metaplasia 01/2020 - 08/2013
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Atrophy 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Chronic Pancreatitis 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Hypoxia (Hypoxemia) 01/2018
1	Melanoma (Melanoma, Malignant) 01/2017
1	Chromosomal Instability (Chromosome Stability) 11/2016

Drug/Important Bio-Agent (IBA)

5	LigandsIBA 01/2021 - 08/2013
4	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2020
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2016
3	CytokinesIBA 01/2022 - 01/2018
3	Gemcitabine FDA Link 01/2020 - 12/2011
2	Immune Checkpoint InhibitorsIBA 01/2020 - 08/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 04/2013
2	CeruletideIBA 01/2020 - 03/2014
1	Glutamine (L-Glutamine)FDA Link 11/2022
1	Activins (Activin)IBA 01/2022
1	activin AIBA 01/2022
1	SugarsIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	AntigensIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	LipidsIBA 01/2022
1	Polysaccharides (Glycans)IBA 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Histone DemethylasesIBA 01/2022
1	CholesterolIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	Biocompatible Materials (Biomaterials)IBA 01/2021
1	sonidegibIBA 01/2021
1	LDL Receptors (LDL Receptor)IBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	Conditioned Culture MediaIBA 01/2021
1	Collagen ReceptorsIBA 01/2020
1	FLP recombinaseIBA 01/2020
1	InterleukinsIBA 01/2020
1	Recombinases (Recombinase)IBA 01/2020
1	Interleukin-22 (IL-22)IBA 01/2020
1	Discoidin Domain Receptor 1IBA 01/2020
1	ChemokinesIBA 01/2020
1	CCR1 ReceptorsIBA 01/2020
1	matrigelIBA 01/2020
1	Codon (Codons)IBA 01/2020
1	Fibrillar CollagensIBA 01/2020
1	trametinibIBA 01/2020
1	beta CateninIBA 01/2020
1	IntegrinsIBA 01/2020
1	ruxolitinibIBA 01/2020
1	CollagenIBA 01/2020
1	Janus KinasesIBA 01/2020
1	Interferon Type IIBA 08/2019
1	InterferonsIBA 08/2019
1	Phosphotransferases (Kinase)IBA 08/2019
1	PyrimidinesIBA 01/2019
1	Phenformin (Fenformin)IBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2015
1	CarcinogensIBA 11/2014
1	Pharmaceutical PreparationsIBA 11/2014
1	mirdametinibIBA 03/2014
1	Mitogen-Activated Protein KinasesIBA 03/2014
1	CateninsIBA 08/2013
1	Biological ProductsIBA 04/2013
1	GTP Phosphohydrolases (GTPases)IBA 02/2012

Therapy/Procedure

11	Therapeutics 01/2022 - 01/2010
4	Immunotherapy 01/2021 - 01/2017
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2020
1	Radiotherapy 01/2021
1	Injections 03/2014